Prot #MR41926: An Exploratory, Prospective, Multi-Center, Open-Label, Single-Arm, Interventional, Phase IIB Study to Investigate Aqueous Humor and Multimodal Imaging Biomarkers in Treatment-Naive Patients with Diabetic Macular Edema Treated with Faricimab

Project: Research project

Project Details

StatusActive
Effective start/end date12/28/2012/28/23

Funding

  • Pharmaceutical Research Associates, Inc. (Prot #MR41926)
  • Genentech, Inc. (Prot #MR41926)